Does TEPOTINIB Cause Malignant neoplasm progression? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Malignant neoplasm progression have been filed in association with TEPOTINIB (TEPMETKO). This represents 2.3% of all adverse event reports for TEPOTINIB.
15
Reports of Malignant neoplasm progression with TEPOTINIB
2.3%
of all TEPOTINIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TEPOTINIB?
Of the 15 reports, 2 (13.3%) resulted in death, 2 (13.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPOTINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TEPOTINIB Cause?
Death (117)
Oedema peripheral (82)
Diarrhoea (57)
Renal impairment (57)
Oedema (56)
Fatigue (53)
Disease progression (50)
Nausea (43)
Off label use (42)
Peripheral swelling (32)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TEPOTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
TEPOTINIB vs TEPROTUMUMAB
TEPOTINIB vs TEPROTUMUMAB-TRBW
TEPOTINIB vs TERAZOSIN
TEPOTINIB vs TERAZOSIN\TERAZOSIN
TEPOTINIB vs TERBINAFINE